Product Code: PM1129
The antithrombotic drugs market size is predicted to reach USD 105.33 billion by 2032, in accordance with a new study by Polaris Market Research. The report "Antithrombotic Drugs Market By Drug Type (Anticoagulant Drug, Antiplatelet Drug, Thrombolytic Drug); By Route of Administration, By Application, By End User, and Geography - Trend, Analysis, and Forecast, 2023-2032" gives a complete foresight into current market dynamics and contribute analysis on future market growth.
Rising cardiovascular disease incidence is anticipated to fuel market expansion over the forecast period. Some of the key factors propelling the growth of the worldwide antiplatelet medicines market are the rising prevalence of cardiovascular illnesses, an aging population, and a sedentary lifestyle. In both developed and developing economies, cardiovascular illnesses constitute the main cause of death.
For instance, according to data from the American Heart Association, at least 3 to 6 million persons in the United States alone had atrial fibrillation in June 2018, and the figure is expected to rise to 6 to 16 million by the year 2050. 3,658 heart transplants were carried out in the United States in 2020. The states of California (496), Texas (302), Florida (288), and New York performed the most heart transplants (250).
The antiplatelet market is influenced by things including the widespread use of antithrombotic/anticoagulant medications, an increase in thrombotic occurrences, an aging population, and recent pharmaceutical advancements.
The market for antithrombotic/anticoagulant medications is anticipated to expand rapidly throughout the forecast period due to factors including the increased availability of these medications and the prevalence of chronic thrombotic diseases that necessitate long-term medication use.
The market for antithrombotic medications is expected to be significantly impacted by COVID-19 infection due to the quick pace of research. According to a study published in the American Journal of Cardiovascular Drugs in 2020, there are currently more than ten clinical trials evaluating the efficacy of antithrombotic medications in COVID-19 patients. Additionally, research is being done on parenteral administration techniques for these medications for using critically ill COVID-19 patients.
Antithrombotic Drugs Market Report Highlights:
Antiplatelet drugs are expected to dominate the market due to increasing use for clotting as arterial clots comprised primarily of platelets, antiplatelet medications are most effective.
Activities by key players in the market for the development of antiplatelet drugs are expected to drive the market growth over the forecast period.
Anticoagulant, Thrombolytic, and oral drugs is expected to hold the largest market share during the forecast period. Anticoagulants work by interfering with several blood coagulation pathways, making them closely connected to antiplatelet medications and thrombolytic therapies.
Some of the key players operating in the market include Daiichi Sankyo Company, Eli Lilly and Company, Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Ko. KG and Aspen Bayer AG, Pfizer, AstraZeneca plc, Johnson & Johnson. AstraZeneca, Otsuka Pharmaceutical, Portola Pharmaceutical Inc., Yuyu Pharma Inc., Limited, Glenmark Pharmaceuticals Limited, China National Pharmaceutical Group Corp, Novartis, Acetlion Pharmaceuticals, Generium Holdings among the others.
Polaris Market Research has segmented the Antithrombotic Drugs market report based on drug type, route of administration, application, end-user and region:
Antithrombotic Drugs market, By Drug Type (Revenue - USD Billion, 2019-2032)
- Antiplatelet Drug
- Anticoagulant Drug
- Thrombolytic Drug
Antithrombotic Drugs market, By Route of Administration (Revenue - USD Billion, 2019-2032)
Antithrombotic Drugs market, By Application (Revenue - USD Billion, 2019-2032)
- Pulmonary Embolism
- Deep Vein Thrombosis
- Atrial Fibrillation
- Others
Antithrombotic Drugs market, By End User (Revenue - USD Billion, 2019-2032)
- Hospitals
- Ambulatory Surgery Centres
- Emergency Service Centres
- Others
Antithrombotic Drugs market, Geography (Revenue - USD Billion, 2019-2032)
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Antithrombotic Drugs Market Insights
- 4.1. Antithrombotic Drugs - Industry Snapshot
- 4.2. Antithrombotic Drugs Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing prevalence of chronic diseases
- 4.2.1.2. Rising number geriatric population
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Side effects linked with antithrombotic drugs
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Antithrombotic Drugs Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Antithrombotic Drugs Market, by Drug Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 5.3. Anticoagulant Drug
- 5.3.1. Global Antithrombotic Drugs Market, by Anticoagulant Drug, by Region, 2019-2032 (USD Billion)
- 5.4. Antiplatelet Drug
- 5.4.1. Global Antithrombotic Drugs Market, by Antiplatelet Drug, by Region, 2019-2032 (USD Billion)
- 5.5. Thrombolytic Drug
- 5.5.1. Global Antithrombotic Drugs Market, by Thrombolytic Drug, by Region, 2019-2032 (USD Billion)
6. Global Antithrombotic Drugs Market, by Route of Administration
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 6.3. Oral
- 6.3.1. Global Antithrombotic Drugs Market, by Oral, by Region, 2019-2032 (USD Billion)
- 6.4. Parenteral
- 6.4.1. Global Antithrombotic Drugs Market, by Parenteral, by Region, 2019-2032 (USD Billion)
7. Global Antithrombotic Drugs Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 7.3. Pulmonary Embolism
- 7.3.1. Global Antithrombotic Drugs Market, by Pulmonary Embolism, by Region, 2019-2032 (USD Billion)
- 7.4. Deep Vein Thrombosis
- 7.4.1. Global Antithrombotic Drugs Market, by Deep Vein Thrombosis, by Region, 2019-2032 (USD Billion)
- 7.5. Atrial Fibrillation
- 7.5.1. Global Antithrombotic Drugs Market, by Atrial Fibrillation, by Region, 2019-2032 (USD Billion)
- 7.6. Others
- 7.6.1. Global Antithrombotic Drugs Market, by Others, by Region, 2019-2032 (USD Billion)
8. Global Antithrombotic Drugs Market, by End User
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 8.3. Hospitals
- 8.3.1. Global Antithrombotic Drugs Market, by Hospitals, by Region, 2019-2032 (USD Billion)
- 8.4. Emergency Service
- 8.4.1. Global Antithrombotic Drugs Market, by Emergency Service, by Region, 2019-2032 (USD Billion)
- 8.5. Centres
- 8.5.1. Global Antithrombotic Drugs Market, by Centres, by Region, 2019-2032 (USD Billion)
- 8.6. Ambulatory Surgery Centres
- 8.6.1. Global Antithrombotic Drugs Market, by Ambulatory Surgery Centres, by Region, 2019-2032 (USD Billion)
- 8.7. Others
- 8.7.1. Global Antithrombotic Drugs Market, by Others, by Region, 2019-2032 (USD Billion)
9. Global Antithrombotic Drugs Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. Antithrombotic Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
- 9.3. Antithrombotic Drugs Market - North America
- 9.3.1. North America: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.3.2. North America: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.3.3. North America: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.3.4. North America: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.3.5. Antithrombotic Drugs Market - U.S.
- 9.3.5.1. U.S.: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.3.5.2. U.S.: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.3.5.3. U.S.: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.3.5.4. U.S.: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.3.6. Antithrombotic Drugs Market - Canada
- 9.3.6.1. Canada: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.3.6.2. Canada: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.3.6.3. Canada: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.3.6.4. Canada: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.4. Antithrombotic Drugs Market - Europe
- 9.4.1. Europe: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.4.2. Europe: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.4.3. Europe: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.4. Europe: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.4.5. Antithrombotic Drugs Market - UK
- 9.4.5.1. UK: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.4.5.2. UK: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.4.5.3. UK: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.5.4. UK: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.4.6. Antithrombotic Drugs Market - France
- 9.4.6.1. France: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.4.6.2. France: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.4.6.3. France: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.6.4. France: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.4.7. Antithrombotic Drugs Market - Germany
- 9.4.7.1. Germany: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.4.7.2. Germany: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.4.7.3. Germany: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.7.4. Germany: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.4.8. Antithrombotic Drugs Market - Italy
- 9.4.8.1. Italy: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.4.8.2. Italy: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.4.8.3. Italy: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.8.4. Italy: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.4.9. Antithrombotic Drugs Market - Spain
- 9.4.9.1. Spain: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.4.9.2. Spain: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.4.9.3. Spain: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.9.4. Spain: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.4.10. Antithrombotic Drugs Market - Netherlands
- 9.4.10.1. Netherlands: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.4.10.2. Netherlands: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.4.10.3. Netherlands: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.10.4. Netherlands: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.4.11. Antithrombotic Drugs Market - Russia
- 9.4.11.1. Russia: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.4.11.2. Russia.: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.4.11.3. Russia: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.11.4. Russia: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.5. Antithrombotic Drugs Market - Asia Pacific
- 9.5.1. Asia Pacific: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.5.2. Asia Pacific: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.5.3. Asia Pacific: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.4. Asia Pacific: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.5.5. Antithrombotic Drugs Market - China
- 9.5.5.1. China: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.5.5.2. China.: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.5.5.3. China: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.5.4. China: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.5.6. Antithrombotic Drugs Market - India
- 9.5.6.1. India: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.5.6.2. India.: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.5.6.3. India: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.6.4. India: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.5.7. Antithrombotic Drugs Market - Japan
- 9.5.7.1. Japan: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.5.7.2. Japan.: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.5.7.3. Japan: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.7.4. Japan: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.5.8. Antithrombotic Drugs Market - Malaysia
- 9.5.8.1. Malaysia: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.5.8.2. Malaysia.: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.5.8.3. Malaysia: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.8.4. Malaysia: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.5.9. Antithrombotic Drugs Market - Indonesia
- 9.5.9.1. Indonesia: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.5.9.2. Indonesia.: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.5.9.3. Indonesia: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.9.4. Indonesia: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.5.10. Antithrombotic Drugs Market - South Korea
- 9.5.10.1. South Korea: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.5.10.2. South Korea.: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.5.10.3. South Korea: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.10.4. South Korea: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.6. Antithrombotic Drugs Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.6.2. Middle East & Africa: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.6.3. Middle East & Africa: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.4. Middle East & Africa: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.6.5. Antithrombotic Drugs Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.6.5.2. Saudi Arabia: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.6.5.3. Saudi Arabia: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.5.4. Saudi Arabia: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.6.6. Antithrombotic Drugs Market - South Africa
- 9.6.6.1. South Africa: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.6.6.2. South Africa: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.6.6.3. South Africa: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.6.4. South Africa: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.6.7. Antithrombotic Drugs Market - Israel
- 9.6.7.1. Israel: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.6.7.2. Israel: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.6.7.3. Israel: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.7.4. Israel: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.6.8. Antithrombotic Drugs Market - UAE
- 9.6.8.1. UAE: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.6.8.2. UAE: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.6.8.3. UAE: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.8.4. UAE: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.7. Antithrombotic Drugs Market - Latin America
- 9.7.1. Latin America: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.7.2. Latin America: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.7.3. Latin America: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.7.4. Latin America: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.7.5. Antithrombotic Drugs Market - Mexico
- 9.7.5.1. Mexico: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.7.5.2. Mexico: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.7.5.3. Mexico: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.7.5.4. Mexico: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.7.6. Antithrombotic Drugs Market - Brazil
- 9.7.6.1. Brazil: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.7.6.2. Brazil: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.7.6.3. Brazil: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.7.6.4. Brazil: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.7.7. Antithrombotic Drugs Market - Argentina
- 9.7.7.1. Argentina: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.7.7.2. Argentina: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
- 9.7.7.3. Argentina: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.7.7.4. Argentina: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Daiichi Sankyo Company
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Eli Lilly and Company
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Bristol-Myers Squibb Company
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. C.H. Boehringer Sohn AG & Ko. KG and Aspen Bayer AG
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Pfizer
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. AstraZeneca plc
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Johnson & Johnson
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. AstraZeneca
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Otsuka Pharmaceutical
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Portola Pharmaceutical Inc
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Yuyu Pharma Inc., Limited
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Glenmark Pharmaceuticals Limited
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
- 11.13. China National Pharmaceutical Group Corp
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
- 11.14. Novartis
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
- 11.15. Acetlion Pharmaceuticals
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development
- 11.16. Generium Holdings
- 11.16.1. Company Overview
- 11.16.2. Financial Performance
- 11.16.3. Product Benchmarking
- 11.16.4. Recent Development